Xenical Research Today is a free monthly online journal that collates and summarizes the latest research about Xenical, including details on orlistat, side-effects, obesity, weight loss, dieting.

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.

Cho L, Kilpatrick E, Keevil B, Coady A, Atkin S

Department of Medicine University of Hull, Hull, UK.

Context: Mean insulin resistance (IR) is greater and it is also more variable in overweight women with polycystic ovarian syndrome (PCOS) compared to weight matched controls. Whilst treatment will reduce the mean IR it is not known if the IR variability is also reduced. Objective: To compare the change in IR and its variability before and after treatment with insulin sensitisation through metformin and pioglitazone, compared to that induced by weight loss with orlistat. Design: Randomised, open labelled parallel study Setting: Endocrinology outpatient clinic at a referral centre Patients: 30 obese PCOS patients [BMI 36.0+/-1.2 kg/m(2) (mean +/- SEM)] participated in the study. Intervention: The change in biological variability was assessed by measuring IR (homeostasis model assessment method) at 4-day intervals on 10 consecutive occasions before and 12 weeks after randomisation to metformin, pioglitazone or orlistat. Outcome measured: The primary end point of the study was a change in biological variability of IR. Results: Treatment with pioglitazone, orlistat and metformin reduced the overall IR by 41.0+/-4.1%, 19.7+/-6.4% and 16.1+/-6.8% (p=0.005, p= 0.013, p=0.17,, respectively) and IR variability by 28.5+/-18.0%, 41.8+/-11.6% and 23.7+/-17.0 (p=0.20, p=0.015 and p=0.28, respectively). Free androgen index reduced significantly with all treatments. Conclusion: Only orlistat reduced both IR and its variability significantly, though all three drugs were effective in reducing hyperandrogenism within the 12 week period of the study.

Published 12 June 2008 in Clin Endocrinol (Oxf).
Full-text of this article is available online (may require subscription).

© 2004-2008 Xenical Research Today. All Rights Reserved.